Ondine Biomedical Inc (LON:OBIMF)

PRESS RELEASE

published on 04/15/2024 at 08:00, 1 year 8 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 1 year 8 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 1 year 8 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 1 year 8 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 1 year 8 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 1 year 8 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 1 year 8 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 1 year 8 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 1 year 8 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 1 year 8 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Published on 12/15/2025 at 09:01, 1 hour 46 minutes ago

Apex Discovers Mineralized Carbonatite at its Lac Le Moyne Project, Québec
Published on 12/14/2025 at 23:00, 11 hours 47 minutes ago

Fortescue to Acquire Alta Copper for C$1.40 per Share
Published on 12/13/2025 at 02:00, 2 days 8 hours ago

Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 2 days 10 hours ago

Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 2 days 11 hours ago

ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence

View all ACCESSWIRE

Published on 12/15/2025 at 10:30, 17 minutes ago

Original-Research: Verve Group SE (von GBC AG): BUY
Published on 12/15/2025 at 10:30, 17 minutes ago

EQS-Adhoc: Gothaer Allgemeine Versicherung AG: BarmeniaGothaer closes its first financial year 2025 with a very good result
Published on 12/15/2025 at 10:15, 32 minutes ago

Now Is Yours: Huawei Rolls Out Mate X7 Alongside a New Lineup of Innovative Products
Published on 12/15/2025 at 10:09, 38 minutes ago

FAVEOS SE concludes strategic framework agreements with leading battery optimizers enspired and Entrix
Published on 12/15/2025 at 10:05, 42 minutes ago

Voltage Energy Secures Industry's First Full-System 2kV EBOS Certification from UL Solutions

View all EQS

Published on 12/12/2025 at 18:00, 2 days 16 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 2 days 16 hours ago

Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
Published on 12/12/2025 at 09:15, 3 days 1 hour ago

CHANGE IN THE SHARE CAPITAL
Published on 12/12/2025 at 09:15, 3 days 1 hour ago

MODIFICATION DE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 15 hours ago

Eiffage is joining the CAC 40 index

View all LES ECHOS COMFI WIRE

News